San Diego medical diagnostics company Accumetrics said Wednesday that its test for measuring the effectiveness of anti-blood clotting medicines will be used in clinical trials of an experimental drug ...
SAN DIEGO, Nov. 19 Accumetrics, Inc., developer of the VerifyNow System, the first point-of-care method for measuring platelet reactivity, announces that its market-leading VerifyNow P2Y12 Test was ...
Accumetrics, Inc., developer of the VerifyNow ® System, the first rapid and easy-to-use point-of-care system for measuring platelet reactivity to multiple antiplatelet agents, today announced that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback